We are pleased to announce that Dr. Frank Borriello, Founder and CEO of Alloplex Biotherapeutics, will be presenting at the upcoming World Oncology Cell Therapy Congress, being held in Boston, MA, on April 25 & 26, 2023. The presentation will include emerging data from the SUPLEXA-101 clinical trial and highlight the development of an unprecedented blood-based pharmacodynamic signature of SUPLEXA activity.
To learn more, please attend the presentation at 2.30 p.m. on April 25th (Track A ‘Clinical Progress in Targeting Solid Tumors’) entitled Preliminary First-in-Human Data from an Exploratory Clinical Trial of SUPLEXA Therapeutic Cells.
The World Oncology Cell Therapy Congress is billed as the only annual meeting that brings together drug developers, investors, solution providers and clinicians whose purpose is to deliver safe and effective adoptive cell therapy products to clinical implementation. For more information, download the agenda here: https://hubs.ly/Q01KPvgd0
To request interviews, high res images or other materials, media are asked to:
Email: media@alloplexbio.com
Attn: Lesley White, Alloplex Australia
For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013
